Citation Impact
Citing Papers
Structure of the human TRPM4 ion channel in a lipid nanodisc
2017 StandoutScienceNobel
The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency
2008 StandoutScienceNobel
Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
2013
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
EGFR Antagonists in Cancer Treatment
2008 Standout
Structure of the TRPA1 ion channel suggests regulatory mechanisms
2015 StandoutNatureNobel
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
2011
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
2009 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Vascular endothelial growth factor receptor‐1 in human cancer
2010
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells
2009
Glioblastoma stem-like cells give rise to tumour endothelium
2010 Nature
Irritant-evoked activation and calcium modulation of the TRPA1 receptor
2020 StandoutNatureNobel
QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochromaffin cells
2009
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways
2005 StandoutNobel
ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
2010
A New Weapon for Attacking Tumor Blood Vessels
2008 StandoutNobel
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
2006
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
2010
Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer
2015
VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex
2012
Angiogenesis in life, disease and medicine
2005 StandoutNature
The semaphorins: versatile regulators of tumour progression and tumour angiogenesis
2008
A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain
2019 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways
2017 StandoutNobel
Primary and acquired resistance to anti-EGFR targeted drugs in cancer therapy
2007
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
2007
Structural snapshots of TRPV1 reveal mechanism of polymodal functionality
2021 StandoutNobel
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Macrophage presence is essential for the regeneration of ascending afferent fibres following a conditioning sciatic nerve lesion in adult rats
2011
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
2011 StandoutNobel
Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1
2013
Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: Implications for tumor progression
2008
Clonal evolution in cancer
2012 StandoutNature
Ingression of primary mesenchyme cells of the sea urchin embryo: A precisely timed epithelial mesenchymal transition
2007
Hypoxia-inducible Factor-1 Deficiency Results in Dysregulated Erythropoiesis Signaling and Iron Homeostasis in Mouse Development
2006 StandoutNobel
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Cancer-related inflammation
2008 StandoutNature
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
2010
Predicting the outcome of chemotherapy for lung cancer
2006
Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver
2008
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Targeting endothelial and tumor cells with semaphorins
2007
Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis
2008
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase
2018 StandoutNobel
Simple yet functional phosphate-loop proteins
2018 StandoutNobel
Early events in cell adhesion and polarity during epithelial-mesenchymal transition
2012
The role of neuropilins in cancer
2006
Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells
2007
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Targeted therapies in control of EMT in carcinoma and fibrosis
2007
Obstacles and opportunities for understanding macrophage polarization
2011
Implications of B7-H1 Expression in Clear Cell Carcinoma of the Kidney for Prognostication and Therapy
2007
Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?
2006 Science
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer
2006
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Cancer Genome Landscapes
2013 StandoutScience
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1α, Leading to Its Oxygen-Independent Degradation
2008
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
One Pathway Can Incorporate either Adenine or Dimethylbenzimidazole as an α-Axial Ligand of B 12 Cofactors in Salmonella enterica
2007
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Structural insights into TRPM8 inhibition and desensitization
2019 StandoutScienceNobel
Works of Michael J. Gray being referenced
Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells
2005
Src activation of Stat3 is an independent requirement from NF-κB activation for constitutive IL-8 expression in human pancreatic adenocarcinoma cells
2006
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Macrophage depletion alters the blood–nerve barrier without affecting Schwann cell function after neural injury
2007
Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells
2007
Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPβ
2005
Polyphosphate Is a Primordial Chaperone
2014
Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines
2005
Vascular Endothelial Growth Factor Receptor-1 Activation Mediates Epithelial to Mesenchymal Transition in Human Pancreatic Carcinoma Cells
2006
Neuropilin-1 Suppresses Tumorigenic Properties in a Human Pancreatic Adenocarcinoma Cell Line Lacking Neuropilin-1 Coreceptors
2005
Single-enzyme conversion of FMNH 2 to 5,6-dimethylbenzimidazole, the lower ligand of B 12
2007
Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
2008
The Development and Characterization of a Human Midgut Carcinoid Cell Line
2007
Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines
2006
Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
2009